The Stability-Indicating Ultra High-Performance Liquid Chromatography with Diode Array Detector and Tandem Mass Spectrometry Method Applied for the Forced Degradation Study of Ritlecitinib: An Appraisal of Green and Blue Metrics

Background/Objectives: Janus kinase inhibitors open new horizons for small-molecule drugs in treating inflammatory bowel disease, with ritlecitinib demonstrating significant efficacy in clinical trials for ulcerative colitis and Crohn’s disease. Ritlecitinib, a second-generation JAK3 inhibitor, is a...

Full description

Saved in:
Bibliographic Details
Main Authors: Jelena Kovačić, Daniela Amidžić Klarić, Nikša Turk, Željko Krznarić, Emma Riordan, Ana Mornar
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/18/1/124
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832587695737536512
author Jelena Kovačić
Daniela Amidžić Klarić
Nikša Turk
Željko Krznarić
Emma Riordan
Ana Mornar
author_facet Jelena Kovačić
Daniela Amidžić Klarić
Nikša Turk
Željko Krznarić
Emma Riordan
Ana Mornar
author_sort Jelena Kovačić
collection DOAJ
description Background/Objectives: Janus kinase inhibitors open new horizons for small-molecule drugs in treating inflammatory bowel disease, with ritlecitinib demonstrating significant efficacy in clinical trials for ulcerative colitis and Crohn’s disease. Ritlecitinib, a second-generation JAK3 inhibitor, is a novel therapeutic agent for alopecia areata and other autoimmune conditions. Methods: A new stability-indicating UHPLC-DAD-MS/MS method was developed, validated, and applied for a forced degradation study of ritlecitinib under ICH guidelines. Results: The method demonstrated high specificity, sensitivity (LOD: 0.04 µg/mL; LOQ: 0.14 µg/mL), precision (RSD ≤ 0.15%), and accuracy (99.9–100.3%). Forced degradation studies under acidic, basic, oxidative, thermal, and photolytic conditions revealed four novel degradation products. Basic degradation followed second-order kinetics, while oxidative degradation followed zero-order kinetics. Conclusions: The validated method reliably characterized ritlecitinib’s stability and degradation products, providing essential data for optimizing formulation, determining proper storage conditions, anticipating drug–excipient interactions, and ensuring quality control. The eco-friendliness and applicability of the developed forced degradation procedure were evaluated using various green and blue metric tools. Incorporating green analytical principles underscores its potential for sustainable pharmaceutical analysis.
format Article
id doaj-art-2415868826a34fda91af36fa7927b0ca
institution Kabale University
issn 1424-8247
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj-art-2415868826a34fda91af36fa7927b0ca2025-01-24T13:45:28ZengMDPI AGPharmaceuticals1424-82472025-01-0118112410.3390/ph18010124The Stability-Indicating Ultra High-Performance Liquid Chromatography with Diode Array Detector and Tandem Mass Spectrometry Method Applied for the Forced Degradation Study of Ritlecitinib: An Appraisal of Green and Blue MetricsJelena Kovačić0Daniela Amidžić Klarić1Nikša Turk2Željko Krznarić3Emma Riordan4Ana Mornar5Department of Pharmaceutical Analysis, Faculty of Pharmacy and Biochemistry, University of Zagreb, 10000 Zagreb, CroatiaDepartment of Pharmaceutical Analysis, Faculty of Pharmacy and Biochemistry, University of Zagreb, 10000 Zagreb, CroatiaDepartment of Gastroenterology, University Hospital Centre, 10000 Zagreb, CroatiaDepartment of Gastroenterology, University Hospital Centre, 10000 Zagreb, CroatiaSchool of Pharmacy, University College Cork, T12 YT20 Cork, IrelandDepartment of Pharmaceutical Analysis, Faculty of Pharmacy and Biochemistry, University of Zagreb, 10000 Zagreb, CroatiaBackground/Objectives: Janus kinase inhibitors open new horizons for small-molecule drugs in treating inflammatory bowel disease, with ritlecitinib demonstrating significant efficacy in clinical trials for ulcerative colitis and Crohn’s disease. Ritlecitinib, a second-generation JAK3 inhibitor, is a novel therapeutic agent for alopecia areata and other autoimmune conditions. Methods: A new stability-indicating UHPLC-DAD-MS/MS method was developed, validated, and applied for a forced degradation study of ritlecitinib under ICH guidelines. Results: The method demonstrated high specificity, sensitivity (LOD: 0.04 µg/mL; LOQ: 0.14 µg/mL), precision (RSD ≤ 0.15%), and accuracy (99.9–100.3%). Forced degradation studies under acidic, basic, oxidative, thermal, and photolytic conditions revealed four novel degradation products. Basic degradation followed second-order kinetics, while oxidative degradation followed zero-order kinetics. Conclusions: The validated method reliably characterized ritlecitinib’s stability and degradation products, providing essential data for optimizing formulation, determining proper storage conditions, anticipating drug–excipient interactions, and ensuring quality control. The eco-friendliness and applicability of the developed forced degradation procedure were evaluated using various green and blue metric tools. Incorporating green analytical principles underscores its potential for sustainable pharmaceutical analysis.https://www.mdpi.com/1424-8247/18/1/124ritlecitinibJAK3 inhibitorstability-indicating methodforced degradation studygreen analytical chemistrydegradation kinetics
spellingShingle Jelena Kovačić
Daniela Amidžić Klarić
Nikša Turk
Željko Krznarić
Emma Riordan
Ana Mornar
The Stability-Indicating Ultra High-Performance Liquid Chromatography with Diode Array Detector and Tandem Mass Spectrometry Method Applied for the Forced Degradation Study of Ritlecitinib: An Appraisal of Green and Blue Metrics
Pharmaceuticals
ritlecitinib
JAK3 inhibitor
stability-indicating method
forced degradation study
green analytical chemistry
degradation kinetics
title The Stability-Indicating Ultra High-Performance Liquid Chromatography with Diode Array Detector and Tandem Mass Spectrometry Method Applied for the Forced Degradation Study of Ritlecitinib: An Appraisal of Green and Blue Metrics
title_full The Stability-Indicating Ultra High-Performance Liquid Chromatography with Diode Array Detector and Tandem Mass Spectrometry Method Applied for the Forced Degradation Study of Ritlecitinib: An Appraisal of Green and Blue Metrics
title_fullStr The Stability-Indicating Ultra High-Performance Liquid Chromatography with Diode Array Detector and Tandem Mass Spectrometry Method Applied for the Forced Degradation Study of Ritlecitinib: An Appraisal of Green and Blue Metrics
title_full_unstemmed The Stability-Indicating Ultra High-Performance Liquid Chromatography with Diode Array Detector and Tandem Mass Spectrometry Method Applied for the Forced Degradation Study of Ritlecitinib: An Appraisal of Green and Blue Metrics
title_short The Stability-Indicating Ultra High-Performance Liquid Chromatography with Diode Array Detector and Tandem Mass Spectrometry Method Applied for the Forced Degradation Study of Ritlecitinib: An Appraisal of Green and Blue Metrics
title_sort stability indicating ultra high performance liquid chromatography with diode array detector and tandem mass spectrometry method applied for the forced degradation study of ritlecitinib an appraisal of green and blue metrics
topic ritlecitinib
JAK3 inhibitor
stability-indicating method
forced degradation study
green analytical chemistry
degradation kinetics
url https://www.mdpi.com/1424-8247/18/1/124
work_keys_str_mv AT jelenakovacic thestabilityindicatingultrahighperformanceliquidchromatographywithdiodearraydetectorandtandemmassspectrometrymethodappliedfortheforceddegradationstudyofritlecitinibanappraisalofgreenandbluemetrics
AT danielaamidzicklaric thestabilityindicatingultrahighperformanceliquidchromatographywithdiodearraydetectorandtandemmassspectrometrymethodappliedfortheforceddegradationstudyofritlecitinibanappraisalofgreenandbluemetrics
AT niksaturk thestabilityindicatingultrahighperformanceliquidchromatographywithdiodearraydetectorandtandemmassspectrometrymethodappliedfortheforceddegradationstudyofritlecitinibanappraisalofgreenandbluemetrics
AT zeljkokrznaric thestabilityindicatingultrahighperformanceliquidchromatographywithdiodearraydetectorandtandemmassspectrometrymethodappliedfortheforceddegradationstudyofritlecitinibanappraisalofgreenandbluemetrics
AT emmariordan thestabilityindicatingultrahighperformanceliquidchromatographywithdiodearraydetectorandtandemmassspectrometrymethodappliedfortheforceddegradationstudyofritlecitinibanappraisalofgreenandbluemetrics
AT anamornar thestabilityindicatingultrahighperformanceliquidchromatographywithdiodearraydetectorandtandemmassspectrometrymethodappliedfortheforceddegradationstudyofritlecitinibanappraisalofgreenandbluemetrics
AT jelenakovacic stabilityindicatingultrahighperformanceliquidchromatographywithdiodearraydetectorandtandemmassspectrometrymethodappliedfortheforceddegradationstudyofritlecitinibanappraisalofgreenandbluemetrics
AT danielaamidzicklaric stabilityindicatingultrahighperformanceliquidchromatographywithdiodearraydetectorandtandemmassspectrometrymethodappliedfortheforceddegradationstudyofritlecitinibanappraisalofgreenandbluemetrics
AT niksaturk stabilityindicatingultrahighperformanceliquidchromatographywithdiodearraydetectorandtandemmassspectrometrymethodappliedfortheforceddegradationstudyofritlecitinibanappraisalofgreenandbluemetrics
AT zeljkokrznaric stabilityindicatingultrahighperformanceliquidchromatographywithdiodearraydetectorandtandemmassspectrometrymethodappliedfortheforceddegradationstudyofritlecitinibanappraisalofgreenandbluemetrics
AT emmariordan stabilityindicatingultrahighperformanceliquidchromatographywithdiodearraydetectorandtandemmassspectrometrymethodappliedfortheforceddegradationstudyofritlecitinibanappraisalofgreenandbluemetrics
AT anamornar stabilityindicatingultrahighperformanceliquidchromatographywithdiodearraydetectorandtandemmassspectrometrymethodappliedfortheforceddegradationstudyofritlecitinibanappraisalofgreenandbluemetrics